CMG Global Holdings’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$223K Hold
3,869
0.09% 99
2026
Q1
$235K Hold
3,869
0.11% 87
2025
Q4
$223K Buy
+3,869
New +$186K 0.1% 91
2025
Q2
Sell
-5,764
Closed -$281K 91
2025
Q1
$281K Sell
5,764
-207
-3% -$12.1K 0.18% 76
2024
Q4
$341K Buy
5,971
+19
+0.3% +$1.06K 0.19% 72
2024
Q3
$308K Buy
+5,952
New +$279K 0.17% 75
2024
Q2
Sell
-4,214
Closed -$229K 94
2024
Q1
$229K Sell
4,214
-285
-6% -$14.5K 0.16% 84
2023
Q4
$222K Sell
4,499
-100
-2% -$5.25K 0.16% 81
2023
Q3
$267K Hold
4,599
0.23% 72
2023
Q2
$294K Sell
4,599
-50
-1% -$3.35K 0.24% 72
2023
Q1
$322K Hold
4,649
0.29% 67
2022
Q4
$334K Hold
4,649
0.32% 63
2022
Q3
$330K Buy
4,649
+22
+0.5% +$1.6K 0.36% 64
2022
Q2
$356K Buy
4,627
+136
+3% +$10.4K 0.37% 64
2022
Q1
$328K Buy
4,491
+74
+2% +$4.97K 0.27% 64
2021
Q4
$275K Hold
4,417
0.18% 74
2021
Q3
$261K Hold
4,417
0.19% 74
2021
Q2
$295K Sell
4,417
-65
-1% -$4.24K 0.22% 73
2021
Q1
$283K Buy
+4,482
New +$279K 0.25% 71

Other funds holding BMY

CMG Global Holdings's BMY Position: Q2 2026 in Review

CMG Global Holdings held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 3,869 shares worth $223K. The position accounts for 0.09% of the portfolio, ranked #99.

CMG Global Holdings first reported a position in BMY in Q1 2021 and has held it in 19 quarters since. The position peaked at $356K in Q2 2022. 1,158 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • CMG Global Holdings held 3,869 shares of Bristol-Myers Squibb worth $223K as of Q2 2026.
  • CMG Global Holdings left its Bristol-Myers Squibb share count unchanged in Q2 2026.
  • Bristol-Myers Squibb made up 0.09% of CMG Global Holdings's portfolio in Q2 2026, its #99 holding.
  • CMG Global Holdings first reported a position in Bristol-Myers Squibb in Q1 2021 and has held it in 19 quarters since.
  • CMG Global Holdings's Bristol-Myers Squibb position peaked at $356K in Q2 2022.
  • 1,158 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on CMG Global Holdings's 13F filing for Q2 2026, filed 28 Jul 2026.